Despite headlines suggesting a ban, the FDA has simply placed BPC-157 in a category requiring further investigation
The research to date reveals that both can provide significant benefits for recovery from musculoskeletal injuries, skin wounds, inflammation, and more
Products are sold under the "research chemical" or "not for human consumption" designation, which is a legal positioning that carries real risk: no GMP oversight is required, no adverse event reporting is required, and the consumer has no regulatory recourse if a product is mislabeled
It is the most studied injectable peptide for musculoskeletal injuries
BPC-157 BPC-157 stands for Body Protection Compound 157
This process supports reliable and repeatable outcomes across research applications